Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai, India

Clinical Infectious Diseases

Volumn 59, Issue 4, 2014, Pages 589-595

  Solomon, Sunil Suhas ^a,b,c   Srikrishnan, Aylur K ^c   Vasudevan, Canjeevaram K ^c   Anand, Santhanam ^c   Kumar, Muniratnam Suresh ^c   Balakrishnan, Pachamuthu ^c   Mehta, Shruti H ^b   Solomon, Suniti ^c   Lucas, Gregory M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

Author keywords

Contingency management; Drug users; HIV; India; Linkage to care

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DRUG USE; EVALUATION STUDY; FEMALE; FOLLOW UP; FOOD; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ECONOMICS; HIV INFECTIONS; ISOLATION AND PURIFICATION; MEDICATION COMPLIANCE; MOTIVATION; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; DRUG USERS; FEMALE; HIV; HIV INFECTIONS; HUMANS; INDIA; MALE; MEDICATION ADHERENCE; MOTIVATION; VIRAL LOAD;

EID: 84905035958     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu324     Document Type: Article

References (27)

1. El-Sadr WM, Serwadda DM, Sista N, Cohen MS. HIV prevention: great achievements, more challenges ahead. J Acquir Immune Defic Syndr 2013; 63(SUPPL. 2):S115-6.
2. Fauci AS, Folkers GK. Toward an AIDS-free generation. JAMA 2012; 308: 343-4.
3. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011; 52: 793-800.
4. United Nations Joint Programme on HIV/AIDS. Global report: UNAIDS report on the global AIDS epidemic. Available at: http://www.unaids.org/en/media/ unaids/contentassets/documents/epidemiology/2012/gr2012/20121120-UNAIDS-Global- Report-2012-en.pdf. Accessed 10 July 2013.
5. United Nations Office on Drugs and Crime. World drug report 2007. Available at: http://www.unodc.org/pdf/research/wdr07/WDR-2007.pdf. Accessed 10 August 2010.
6. Solomon SS, Srikrishnan AK, Mehta SH, et al. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern. J Acquir Immune Defic Syndr 2008; 49: 327-32.
7. Solomon SS, Celentano DD, Srikrishnan AK, et al. Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India. Am J Epidemiol 2010; 172: 1259-67.
8. Solomon SS, Celentano DD, Srikrishnan AK, et al. Mortality among injection drug users in Chennai, India (2005-2008). AIDS 2009; 23: 997-1004.
9. Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA 2007; 298: 2415-7.
10. Hser YI, Li J, Jiang H, et al. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction 2011; 106: 1801-9.
11. Volpp KG, Troxel AB, Pauly MV, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med 2009; 360: 699-709.
12. Kullgren JT, Troxel AB, Loewenstein G, et al. Individual-versus group-based financial incentives for weight loss: a randomized, controlled trial. Ann Intern Med 2013; 158: 505-14.
13. Thornton RL The demand for, and impact of, learning HIV status. Am Econ Rev 2008; 98: 1829-63.
14. Rigsby MO, Rosen MI, Beauvais JE, et al. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J Gen Intern Med 2000; 15: 841-7.
15. Rosen MI, Dieckhaus K, McMahon TJ, et al. Improved adherence with contingency management. AIDS Patient Care STDS 2007; 21: 30-40.
16. Sorensen JL, Haug NA, Delucchi KL, et al. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend 2007; 88: 54-63.
17. Solomon SS, Hawcroft CS, Narasimhan P, et al. Comorbidities among HIV-infected injection drug users in Chennai, India. Indian J Med Res 2008; 127: 447-52.
18. Pujari S, Patel A, Joshi SR, et al. Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008). J Assoc Phys India 2008; 56: 339-48, 353-71.
19. Solomon SS, Desai M, Srikrishnan AK, et al. The profile of injection drug users in Chennai, India: identification of risk behaviours and implications for interventions. Subst Use Misuse 2010; 45: 354-67.
20. Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr 2001; 27: 251-9.
21. Baird S, Chirwa E, McIntosh C, Ozler B. The short-term impacts of a schooling conditional cash transfer program on the sexual behavior of young women. Health Econ 2010; 19(suppl): 55-68.
22. Javanbakht M, Prosser P, Grimes T, Weinstein M, Farthing C. Efficacy of an individualized adherence support program with contingent reinforcement among nonadherent HIV-positive patients: results from a randomized trial. J Int Assoc Physicians AIDS Care (Chic) 2006; 5: 143-50.
23. HIV Prevention Trials Network. HPTN 065 (TLC-PLUS): a study to evalauate the feasibility of an enhanced test, link to care, plus treat approach for HIV prevention in the United States. Available at: http://www.hptn.org/research- studies/hptn065.asp. Accessed 10 July 2013.
24. Clinical Trials Network. Protocol NIDA-CTN-0049 (Project Hope): hospital visit as opportunity for prevention and engagement for HIV-infected drug users. Available at: http://ctndisseminationlibrary.org/protocols/ctn0049.htm. Accessed 10 July 2013.
25. Gardner EM, Hullsiek KH, Telzak EE, et al. Antiretroviral medication adherence and class-specific resistance in a large prospective clinical trial. AIDS 2010; 24: 395-403.
26. Stitzer M, Petry N. Contingency management for treatment of substance abuse. Annu Rev Clin Psychol 2006; 2: 411-34.
27. Balakrishnan P, Kumarasamy N, Kantor R, et al. HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India. AIDS Res Hum Retroviruses 2005; 21: 301-5.